Stanford University
Showing 761-780 of 998 Results
-
Charles William Ryan
Affiliate, Department Funds
Resident in SurgeryBioI was born and raised in Syracuse, New York. I first attended Onondaga Community College, where I developed a fascination with the development of complex biological systems, and then transferred to Syracuse University where I completed my B.S. in biochemistry. I next attended the University of Michigan MD/PhD program, where I used in-vitro models of human neurodevelopment to study to role of epigenetic marks in guiding neurogenesis. While at Michigan, I became interested in the prospect of harnessing in-vitro differentiation to cultivate functional tissues that can be transplanted to replace what is lost in degenerative conditions. Ophthalmology, with its microsurgical access to functionally critical cell layers, is well-positioned to capitalize on this emerging field of science to treat degenerative conditions. I am humbled and incredibly thankful to have the opportunity to pursue this aim as a SOAR resident at Stanford.
-
Kathleen M. Sakamoto
Shelagh Galligan Professor in the School of Medicine
Current Research and Scholarly InterestsMy research focuses on the molecular pathways that regulate normal and aberrant blood cell development, including acute leukemia and bone marrow failure syndromes. We are also studying novel drugs for treatment of cancer.
-
Cintia Kimura
Affiliate, Department Funds
Resident in SurgeryBioGraduated from Medical School from Universidade de São Paulo (2013). Completed surgical training in General Surgery (2016) and Colorectal Surgery (2018) at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil.
Dr. Kimura obtained a PhD degree on anal cancer screening strategies at Universidade de São Paulo (2021) and an MPH degree with concentration in Epidemiology at Harvard T. H. Chan School of Public Health (2023).
Her current research focuses on how the gut microbiome can affect patients' risk of developing complications after colorectal surgery, and whether it can be modulated by short-term dietary interventions.
Her previous work focused on prevention and early treatment of anal and rectal cancer, and on the interaction between HPV infection and anal neoplasia. -
Lilyane Saleh
Affiliate, Department Funds
Fellow in Rad/Musculoskeletal ImagingBioDr. Lilyane Saleh is a Musculoskeletal Radiology Fellow at Stanford University. She completed her Diagnostic Radiology residency at the University of Toronto, where she received comprehensive training across major academic hospitals and gained experience in a broad range of subspecialties.
Originally trained as a physician in Lebanon, Dr. Saleh later earned her Canadian MD from Université de Montréal. She was one of only a handful of international medical students selected to enter the Quebec medical system through an extremely competitive pathway. Her diverse training and background have shaped a thoughtful approach to patient care and collaboration.
During residency, Dr. Saleh held several leadership roles including Co-Chair of the Social and Wellness Committee, and RSNA Resident Representative. She was recognized with multiple honors such as the Citizenship Award (2025) for her professionalism and community impact, the PGY-1 Clinical Performance Award, and the Social Committee Chair Award. She has also contributed to resident education and mentorship.
She is trilingual in English, Arabic, and French and enjoys swimming, exploring new cities, and spending time with her family. -
Alexander Isaac Salter
Affiliate, Department Funds
Fellow in Medicine - Med/HematologyBioI am a clinical fellow in medical oncology at Stanford University whose long-term goal is to become a translational physician-scientist who develops curative cellular immunotherapies for solid tumors. As a graduate student, I conducted the first comprehensive signaling analyses of therapeutically engineered T cells, demonstrating that signal strength, rather than quality, is a key determinant of T cell function and fate. These findings helped inform the design of next-generation cellular immunotherapies, some of which are now in clinical trials. I also co-led a collaboration with Dr. David Baker’s laboratory at the University of Washington to engineer synthetic protein “logic gates” enabling combinatorial antigen recognition with high precision, offering a potential path to more safely target solid tumors. My doctoral research resulted in 16 publications, including four prominent first-, co-first-, or second-author papers in high-impact journals, several reviews and textbook chapters, and recognition on the Forbes 30 Under 30 List.
At Stanford, I focus on translating cellular therapies for thoracic and genitourinary malignancies. Under the mentorship of Drs. Crystal Mackall and Allison Betof Warner, I am developing CAR T cells for lung cancer in non- and never-smokers and serve as a sub-investigator on an upcoming first-in-human phase 1 trial of drug-regulatable CAR T cells for adults with advanced solid tumors.
